市場調査レポート

商品コード

1462019

関節炎治療の世界市場の規模、シェア、動向分析：用途別、製品タイプ別、地域別展望と予測（2023年～2030年）

Global Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Regional Outlook and Forecast, 2023 - 2030

出版日: 2024年03月21日 | 発行: KBV Research

| ページ情報: 英文 221 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,600 565,704円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,320 678,844円

レポートPDFを同一企業内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprisewide License)

USD 6,048 950,382円

レポートPDFを同一企業のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の関節炎治療の市場規模は、2030年までに1,126億米ドルに達し、予測期間中にCAGR5.1%で成長すると予測されています。

さらに、補完代替療法には、鍼治療、マッサージ療法、ヨガ、太極拳、栄養補助食品、ハーブ療法、心身療法など、さまざまな治療法が含まれます。したがって、補完代替療法への注目が高まっているため、市場は大幅に拡大すると予想されます。

しかし、関節炎治療の高額な費用は、患者、特に十分な保険に加入していない患者や資金が限られている患者に大きな経済的負担を課します。関節炎管理の経済的負担は、投薬の制限、投薬の省略、必要な医療介入の先送りにつながり、最終的には治療効果と患者の転帰を損ないます。したがって、高額な費用は市場成長を鈍化させる可能性があります。

COVID-19パンデミックにより、外来診療、選択的処置、緊急を要しない医療予約などの日常的なヘルスケアサービスが中断し、関節炎の診断、治療開始、疾患のモニタリングに遅れが生じました。COVID-19パンデミックにより、世界の医薬品サプライチェーンが混乱し、生物学的療法や専門医薬品を含む特定の関節炎治療の不足、在庫切れ、入手の遅れが生じました。したがって、 COVID-19パンデミックは市場にある程度の影響を及ぼしました。

北米の関節炎治療市場
- 用途別
- 製品タイプ別
- 国別
  - 米国の関節炎治療市場
  - カナダの関節炎治療市場
  - メキシコの関節炎治療市場
  - その他北米の関節炎治療市場
欧州の関節炎治療市場
- 用途別
- 製品タイプ別
- 国別
  - ドイツの関節炎治療市場
  - 英国の関節炎治療市場
  - フランスの関節炎治療市場
  - ロシアの関節炎治療市場
  - スペインの関節炎治療市場
  - イタリアの関節炎治療市場
  - その他欧州の関節炎治療市場
アジア太平洋の関節炎治療市場
- 用途別
- 製品タイプ別
- 国別
  - 中国の関節炎治療市場
  - 日本の関節炎治療市場
  - インドの関節炎治療市場
  - 韓国の関節炎治療市場
  - シンガポールの関節炎治療市場
  - マレーシアの関節炎治療市場
  - その他アジア太平洋の関節炎治療市場
ラテンアメリカ・中東・アフリカの関節炎治療市場
- 用途別
- 製品タイプ別
- 国別
  - ブラジルの関節炎治療市場
  - アルゼンチンの関節炎治療市場
  - アラブ首長国連邦の関節炎治療市場
  - サウジアラビアの関節炎治療市場
  - 南アフリカの関節炎治療市場
  - ナイジェリアの関節炎治療市場
  - その他ラテンアメリカ・中東・アフリカの関節炎治療市場

第8章企業プロファイル

AbbVie, Inc
Pfizer, Inc
Amgen, Inc
Novartis AG
F Hoffmann-La Roche Ltd.
Viatris, Inc
Bausch Health Companies, Inc
Sanofi SA
Merck & Co, Inc.
Bristol-Myers Squibb Company

第9章関節炎治療市場の成功必須条件

図表

LIST OF TABLES

TABLE 1Global Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2Global Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3Global Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4Global Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5Global Rheumatoid Arthritis Market, by Region, 2019 - 2022, USD Million
TABLE 6Global Rheumatoid Arthritis Market, by Region, 2023 - 2030, USD Million
TABLE 7Global Psoriatic Arthritis Market, by Region, 2019 - 2022, USD Million
TABLE 8Global Psoriatic Arthritis Market, by Region, 2023 - 2030, USD Million
TABLE 9Global Osteoarthritis Market, by Region, 2019 - 2022, USD Million
TABLE 10Global Osteoarthritis Market, by Region, 2023 - 2030, USD Million
TABLE 11Global Ankylosing Spondylitis Market, by Region, 2019 - 2022, USD Million
TABLE 12Global Ankylosing Spondylitis Market, by Region, 2023 - 2030, USD Million
TABLE 13Global Others Market, by Region, 2019 - 2022, USD Million
TABLE 14Global Others Market, by Region, 2023 - 2030, USD Million
TABLE 15Global Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16Global Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Region, 2019 - 2022, USD Million
TABLE 18Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Region, 2023 - 2030, USD Million
TABLE 19Global Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Region, 2019 - 2022, USD Million
TABLE 20Global Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Region, 2023 - 2030, USD Million
TABLE 21Global Biologics Market, by Region, 2019 - 2022, USD Million
TABLE 22Global Biologics Market, by Region, 2023 - 2030, USD Million
TABLE 23Global Others Market, by Region, 2019 - 2022, USD Million
TABLE 24Global Others Market, by Region, 2023 - 2030, USD Million
TABLE 25Global Arthritic Therapeutic Market, by Region, 2019 - 2022, USD Million
TABLE 26Global Arthritic Therapeutic Market, by Region, 2023 - 2030, USD Million
TABLE 27North America Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28North America Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29North America Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30North America Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31North America Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 32North America Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 33North America Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 34North America Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 35North America Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 36North America Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 37North America Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 38North America Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 39North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 40North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 41North America Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 42North America Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 43North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 44North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 45North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 46North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 47North America Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 48North America Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 49North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 50North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 51North America Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 52North America Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 53US Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 54US Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 55US Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 56US Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 57US Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 58US Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 59Canada Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 60Canada Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 61Canada Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 62Canada Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 63Canada Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 64Canada Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 65Mexico Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 66Mexico Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 67Mexico Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 68Mexico Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 69Mexico Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 70Mexico Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 71Rest of North America Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 72Rest of North America Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 73Rest of North America Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 74Rest of North America Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 75Rest of North America Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 76Rest of North America Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 77Europe Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 78Europe Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 79Europe Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 80Europe Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 81Europe Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 82Europe Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 83Europe Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 84Europe Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 85Europe Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 86Europe Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 87Europe Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 88Europe Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 89Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 90Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 91Europe Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 92Europe Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 93Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 94Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 95Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 96Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 97Europe Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 98Europe Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 99Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 100Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 101Europe Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 102Europe Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 103Germany Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 104Germany Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 105Germany Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 106Germany Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 107Germany Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 108Germany Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 109UK Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 110UK Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 111UK Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 112UK Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 113UK Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 114UK Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 115France Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 116France Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 117France Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 118France Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 119France Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 120France Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 121Russia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 122Russia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 123Russia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 124Russia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 125Russia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 126Russia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 127Spain Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 128Spain Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 129Spain Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 130Spain Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 131Spain Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 132Spain Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 133Italy Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 134Italy Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 135Italy Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 136Italy Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 137Italy Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 138Italy Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 139Rest of Europe Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 140Rest of Europe Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 141Rest of Europe Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 142Rest of Europe Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 143Rest of Europe Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 144Rest of Europe Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 145Asia Pacific Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 146Asia Pacific Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 147Asia Pacific Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 148Asia Pacific Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 149Asia Pacific Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 150Asia Pacific Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 151Asia Pacific Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 152Asia Pacific Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 153Asia Pacific Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 154Asia Pacific Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 155Asia Pacific Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 156Asia Pacific Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 157Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 158Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 159Asia Pacific Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 160Asia Pacific Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 161Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 162Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 163Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 164Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 165Asia Pacific Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 166Asia Pacific Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 167Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 168Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 169Asia Pacific Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 170Asia Pacific Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 171China Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 172China Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 173China Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 174China Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 175China Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 176China Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 177Japan Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 178Japan Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 179Japan Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 180Japan Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 181Japan Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 182Japan Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 183India Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 184India Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 185India Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 186India Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 187India Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 188India Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 189South Korea Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 190South Korea Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 191South Korea Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 192South Korea Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 193South Korea Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 194South Korea Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 195Singapore Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 196Singapore Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 197Singapore Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 198Singapore Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 199Singapore Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 200Singapore Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 201Malaysia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 202Malaysia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 203Malaysia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 204Malaysia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 205Malaysia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 206Malaysia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 207Rest of Asia Pacific Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 208Rest of Asia Pacific Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 209Rest of Asia Pacific Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 210Rest of Asia Pacific Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 211Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 212Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 213LAMEA Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 214LAMEA Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 215LAMEA Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 216LAMEA Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 217LAMEA Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 218LAMEA Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 219LAMEA Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 220LAMEA Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 221LAMEA Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 222LAMEA Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 223LAMEA Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 224LAMEA Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 225LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 226LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 227LAMEA Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 228LAMEA Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 229LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 230LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 231LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 232LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 233LAMEA Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 234LAMEA Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 235LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 236LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 237LAMEA Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 238LAMEA Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 239Brazil Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 240Brazil Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 241Brazil Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 242Brazil Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 243Brazil Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 244Brazil Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 245Argentina Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 246Argentina Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 247Argentina Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 248Argentina Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 249Argentina Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 250Argentina Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 251UAE Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 252UAE Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 253UAE Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 254UAE Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 255UAE Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 256UAE Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 257Saudi Arabia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 258Saudi Arabia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 259Saudi Arabia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 260Saudi Arabia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 261Saudi Arabia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 262Saudi Arabia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 263South Africa Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 264South Africa Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 265South Africa Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 266South Africa Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 267South Africa Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 268South Africa Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 269Nigeria Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 270Nigeria Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 271Nigeria Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 272Nigeria Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 273Nigeria Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 274Nigeria Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 275Rest of LAMEA Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 276Rest of LAMEA Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 277Rest of LAMEA Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 278Rest of LAMEA Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 279Rest of LAMEA Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 280Rest of LAMEA Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 281Key information - AbbVie, Inc.
TABLE 282Key Information - Pfizer, Inc.
TABLE 283Key Information - Amgen, Inc.
TABLE 284Key Information - Novartis AG
TABLE 285Key Information - F. Hoffmann-La Roche Ltd.
TABLE 286Key Information - Viatris, Inc.
TABLE 287key information - Bausch Health Companies, Inc.
TABLE 288Key Information - Sanofi S.A.
TABLE 289Key Information - Merck & Co., Inc.
TABLE 290Key Information - Bristol-Myers Squibb Company

The Global Arthritic Therapeutic Market size is expected to reach $112.6 billion by 2030, rising at a market growth of 5.1% CAGR during the forecast period.

The osteoarthritis segment encompasses a diverse array of treatment modalities, including pharmacological interventions, non-pharmacological therapies, and surgical interventions. Therefore, the osteoarthritis segment captured $7,913.2 million revenue in the market in 2022. Pharmaceutical companies develop and market a range of medications for osteoarthritis, including analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and viscosupplementation agents, to provide symptom relief and improve joint function.

As the prevalence of arthritis continues to rise globally, there is a growing population of individuals affected by the disease. This expanding patient population creates a larger market for arthritis therapies, including pharmacological interventions, non-pharmacological treatments, surgical procedures, and assistive devices, driving demand for arthritis treatments, and supporting market growth. Therefore, the market is expanding significantly due to the growing prevalence of arthritis.

Additionally, complementary and alternative therapies encompass various treatment modalities, including acupuncture, massage therapy, yoga, tai chi, dietary supplements, herbal remedies, and mind-body techniques. Thus, because of the rising focus on complementary and alternative therapies, the market is anticipated to increase significantly.

However, The high cost of arthritis therapeutics places a substantial financial burden on patients, particularly those without adequate insurance coverage or limited financial resources. The financial burden of arthritis management can contribute to medication rationing, skipping doses, or preceding necessary medical interventions, ultimately compromising treatment efficacy and patient outcomes. Thus, high cost can slow down the growth of the market.

The COVID-19 pandemic disrupted routine healthcare services, including outpatient visits, elective procedures, and non-urgent medical appointments, leading to delays in arthritis diagnosis, treatment initiation, and disease monitoring. The COVID-19 pandemic disrupted global drug supply chains, leading to shortages, stockouts, and delays in the availability of certain arthritic medications, including biologic therapies and specialty drugs. Thus, the COVID-19 pandemic had a moderate effect on the market.

By Application Analysis

Based on application, the market is classified into rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis, and others. The psoriatic arthritis segment acquired 12.9% revenue share in the market in 2022. Psoriatic arthritis represents a significant unmet medical need, as it affects individuals with psoriasis, a common skin condition, and can lead to progressive joint damage, disability, and impaired quality of life if left untreated.

By Product Type Analysis

By product type, the market is categorized into non-steroidal anti-inflammatory drugs (NSAIDs), disease modified anti-rheumatoid drugs (DMARDs), biologics, and others. In 2022, the non-steroidal anti-inflammatory drugs (NSAIDs) segment held 38.7% revenue share in the market. NSAIDs are instrumental in managing various symptoms associated with arthritis, including pain, swelling, stiffness, and functional impairment.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific region acquired 23.4% revenue share in the market. Urbanization and lifestyle changes in the Asia Pacific region, including sedentary lifestyles, unhealthy diets, obesity, and physical inactivity, contribute to the rising prevalence of arthritis.

Recent Strategies Deployed in the Market

2023-Oct: Amgen, Inc. completed the acquisition of Horizon Therapeutics plc, a biopharmaceutical company. Through this acquisition, Horizon will help to further establish Amgen as a leader across a broader range of diseases. Furthermore, the companies will collaborate to serve even more patients worldwide who are suffering from serious illnesses.
2022-Oct: Pfizer Inc. completed the acquisition of Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company. Through this acquisition, Pfizer enhanced its product portfolio of potential calcitonin gene-related peptide (CGRP) receptor antagonists.
2022-Mar: Pfizer, Inc. completed the acquisition of Arena Pharmaceuticals, Inc., a clinical-stage company. Under this acquisition, Arena Pharmaceuticals will give Pfizer access to a collection of different and promising experimental treatments in areas like stomach and intestine health, skin conditions, and heart-related issues.
2021-Dec: Novartis AG received approval from the US Food and Drug Administration (FDA) for Cosentyx (secukinumab), which is required for the treatment of active enthesitis-related arthritis (ERA) in patients four years and older and active juvenile psoriatic arthritis (JPsA) in patients two years and older. Cosentyx is the first biologic indicated for ERA and the only biologic treatment approved for both ERA and PsA in paediatric patients in the US. The approved paediatric dosing for Cosentyx in children and adolescents is 75 mg (15 kg or more to less than 50 kg) or 150 mg (50 kg or more).
2020-Oct: Merck & Co., Inc. came into an agreement with Novartis AG, a Swiss multinational pharmaceutical corporation. Under this agreement, the M6495, an anti-ADAMTS5 Nanobody intended for potential osteoarthritis (OA) therapy, was introduced. The new product is designed to be administered via self-injection under the skin, with the goal of preserving knee joint structural integrity and alleviating pain.

List of Key Companies Profiled

AbbVie, Inc.
Pfizer, Inc.
Amgen, Inc.
Novartis AG
F. Hoffmann-La Roche Ltd.
Viatris, Inc.
Bausch Health Companies, Inc.
Sanofi S.A.
Merck & Co., Inc.
Bristol-Myers Squibb Company

Global Arthritic Therapeutic Market Report Segmentation

By Application

Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Ankylosing Spondylitis
Others

By Product Type

Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Disease Modified Anti-rheumatoid Drugs (DMARDs)
Biologics
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Global Arthritic Therapeutic Market, by Application
- 1.4.2Global Arthritic Therapeutic Market, by Product Type
- 1.4.3Global Arthritic Therapeutic Market, by Geography
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5.Global Arthritic Therapeutic Market, by Application

5.1Global Rheumatoid Arthritis Market, by Region
5.2Global Psoriatic Arthritis Market, by Region
5.3Global Osteoarthritis Market, by Region
5.4Global Ankylosing Spondylitis Market, by Region
5.5Global Others Market, by Region

Chapter 6.Global Arthritic Therapeutic Market, by Product Type

6.1Global Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Region
6.2Global Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Region
6.3Global Biologics Market, by Region
6.4Global Others Market, by Region

Chapter 7.Global Arthritic Therapeutic Market, by Region

7.1North America Arthritic Therapeutic Market
- 7.1.1North America Arthritic Therapeutic Market, by Application
  - 7.1.1.1North America Rheumatoid Arthritis Market, by Country
  - 7.1.1.2North America Psoriatic Arthritis Market, by Country
  - 7.1.1.3North America Osteoarthritis Market, by Country
  - 7.1.1.4North America Ankylosing Spondylitis Market, by Country
  - 7.1.1.5North America Others Market, by Country
- 7.1.2North America Arthritic Therapeutic Market, by Product Type
  - 7.1.2.1North America Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
  - 7.1.2.2North America Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
  - 7.1.2.3North America Biologics Market, by Country
  - 7.1.2.4North America Others Market, by Country
- 7.1.3North America Arthritic Therapeutic Market, by Country
  - 7.1.3.1US Arthritic Therapeutic Market
    - 7.1.3.1.1US Arthritic Therapeutic Market, by Application
    - 7.1.3.1.2US Arthritic Therapeutic Market, by Product Type
  - 7.1.3.2Canada Arthritic Therapeutic Market
    - 7.1.3.2.1Canada Arthritic Therapeutic Market, by Application
    - 7.1.3.2.2Canada Arthritic Therapeutic Market, by Product Type
  - 7.1.3.3Mexico Arthritic Therapeutic Market
    - 7.1.3.3.1Mexico Arthritic Therapeutic Market, by Application
    - 7.1.3.3.2Mexico Arthritic Therapeutic Market, by Product Type
  - 7.1.3.4Rest of North America Arthritic Therapeutic Market
    - 7.1.3.4.1Rest of North America Arthritic Therapeutic Market, by Application
    - 7.1.3.4.2Rest of North America Arthritic Therapeutic Market, by Product Type
7.2Europe Arthritic Therapeutic Market
- 7.2.1Europe Arthritic Therapeutic Market, by Application
  - 7.2.1.1Europe Rheumatoid Arthritis Market, by Country
  - 7.2.1.2Europe Psoriatic Arthritis Market, by Country
  - 7.2.1.3Europe Osteoarthritis Market, by Country
  - 7.2.1.4Europe Ankylosing Spondylitis Market, by Country
  - 7.2.1.5Europe Others Market, by Country
- 7.2.2Europe Arthritic Therapeutic Market, by Product Type
  - 7.2.2.1Europe Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
  - 7.2.2.2Europe Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
  - 7.2.2.3Europe Biologics Market, by Country
  - 7.2.2.4Europe Others Market, by Country
- 7.2.3Europe Arthritic Therapeutic Market, by Country
  - 7.2.3.1Germany Arthritic Therapeutic Market
    - 7.2.3.1.1Germany Arthritic Therapeutic Market, by Application
    - 7.2.3.1.2Germany Arthritic Therapeutic Market, by Product Type
  - 7.2.3.2UK Arthritic Therapeutic Market
    - 7.2.3.2.1UK Arthritic Therapeutic Market, by Application
    - 7.2.3.2.2UK Arthritic Therapeutic Market, by Product Type
  - 7.2.3.3France Arthritic Therapeutic Market
    - 7.2.3.3.1France Arthritic Therapeutic Market, by Application
    - 7.2.3.3.2France Arthritic Therapeutic Market, by Product Type
  - 7.2.3.4Russia Arthritic Therapeutic Market
    - 7.2.3.4.1Russia Arthritic Therapeutic Market, by Application
    - 7.2.3.4.2Russia Arthritic Therapeutic Market, by Product Type
  - 7.2.3.5Spain Arthritic Therapeutic Market
    - 7.2.3.5.1Spain Arthritic Therapeutic Market, by Application
    - 7.2.3.5.2Spain Arthritic Therapeutic Market, by Product Type
  - 7.2.3.6Italy Arthritic Therapeutic Market
    - 7.2.3.6.1Italy Arthritic Therapeutic Market, by Application
    - 7.2.3.6.2Italy Arthritic Therapeutic Market, by Product Type
  - 7.2.3.7Rest of Europe Arthritic Therapeutic Market
    - 7.2.3.7.1Rest of Europe Arthritic Therapeutic Market, by Application
    - 7.2.3.7.2Rest of Europe Arthritic Therapeutic Market, by Product Type
7.3Asia Pacific Arthritic Therapeutic Market
- 7.3.1Asia Pacific Arthritic Therapeutic Market, by Application
  - 7.3.1.1Asia Pacific Rheumatoid Arthritis Market, by Country
  - 7.3.1.2Asia Pacific Psoriatic Arthritis Market, by Country
  - 7.3.1.3Asia Pacific Osteoarthritis Market, by Country
  - 7.3.1.4Asia Pacific Ankylosing Spondylitis Market, by Country
  - 7.3.1.5Asia Pacific Others Market, by Country
- 7.3.2Asia Pacific Arthritic Therapeutic Market, by Product Type
  - 7.3.2.1Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
  - 7.3.2.2Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
  - 7.3.2.3Asia Pacific Biologics Market, by Country
  - 7.3.2.4Asia Pacific Others Market, by Country
- 7.3.3Asia Pacific Arthritic Therapeutic Market, by Country
  - 7.3.3.1China Arthritic Therapeutic Market
    - 7.3.3.1.1China Arthritic Therapeutic Market, by Application
    - 7.3.3.1.2China Arthritic Therapeutic Market, by Product Type
  - 7.3.3.2Japan Arthritic Therapeutic Market
    - 7.3.3.2.1Japan Arthritic Therapeutic Market, by Application
    - 7.3.3.2.2Japan Arthritic Therapeutic Market, by Product Type
  - 7.3.3.3India Arthritic Therapeutic Market
    - 7.3.3.3.1India Arthritic Therapeutic Market, by Application
    - 7.3.3.3.2India Arthritic Therapeutic Market, by Product Type
  - 7.3.3.4South Korea Arthritic Therapeutic Market
    - 7.3.3.4.1South Korea Arthritic Therapeutic Market, by Application
    - 7.3.3.4.2South Korea Arthritic Therapeutic Market, by Product Type
  - 7.3.3.5Singapore Arthritic Therapeutic Market
    - 7.3.3.5.1Singapore Arthritic Therapeutic Market, by Application
    - 7.3.3.5.2Singapore Arthritic Therapeutic Market, by Product Type
  - 7.3.3.6Malaysia Arthritic Therapeutic Market
    - 7.3.3.6.1Malaysia Arthritic Therapeutic Market, by Application
    - 7.3.3.6.2Malaysia Arthritic Therapeutic Market, by Product Type
  - 7.3.3.7Rest of Asia Pacific Arthritic Therapeutic Market
    - 7.3.3.7.1Rest of Asia Pacific Arthritic Therapeutic Market, by Application
    - 7.3.3.7.2Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type
7.4LAMEA Arthritic Therapeutic Market
- 7.4.1LAMEA Arthritic Therapeutic Market, by Application
  - 7.4.1.1LAMEA Rheumatoid Arthritis Market, by Country
  - 7.4.1.2LAMEA Psoriatic Arthritis Market, by Country
  - 7.4.1.3LAMEA Osteoarthritis Market, by Country
  - 7.4.1.4LAMEA Ankylosing Spondylitis Market, by Country
  - 7.4.1.5LAMEA Others Market, by Country
- 7.4.2LAMEA Arthritic Therapeutic Market, by Product Type
  - 7.4.2.1LAMEA Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
  - 7.4.2.2LAMEA Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
  - 7.4.2.3LAMEA Biologics Market, by Country
  - 7.4.2.4LAMEA Others Market, by Country
- 7.4.3LAMEA Arthritic Therapeutic Market, by Country
  - 7.4.3.1Brazil Arthritic Therapeutic Market
    - 7.4.3.1.1Brazil Arthritic Therapeutic Market, by Application
    - 7.4.3.1.2Brazil Arthritic Therapeutic Market, by Product Type
  - 7.4.3.2Argentina Arthritic Therapeutic Market
    - 7.4.3.2.1Argentina Arthritic Therapeutic Market, by Application
    - 7.4.3.2.2Argentina Arthritic Therapeutic Market, by Product Type
  - 7.4.3.3UAE Arthritic Therapeutic Market
    - 7.4.3.3.1UAE Arthritic Therapeutic Market, by Application
    - 7.4.3.3.2UAE Arthritic Therapeutic Market, by Product Type
  - 7.4.3.4Saudi Arabia Arthritic Therapeutic Market
    - 7.4.3.4.1Saudi Arabia Arthritic Therapeutic Market, by Application
    - 7.4.3.4.2Saudi Arabia Arthritic Therapeutic Market, by Product Type
  - 7.4.3.5South Africa Arthritic Therapeutic Market
    - 7.4.3.5.1South Africa Arthritic Therapeutic Market, by Application
    - 7.4.3.5.2South Africa Arthritic Therapeutic Market, by Product Type
  - 7.4.3.6Nigeria Arthritic Therapeutic Market
    - 7.4.3.6.1Nigeria Arthritic Therapeutic Market, by Application
    - 7.4.3.6.2Nigeria Arthritic Therapeutic Market, by Product Type
  - 7.4.3.7Rest of LAMEA Arthritic Therapeutic Market
    - 7.4.3.7.1Rest of LAMEA Arthritic Therapeutic Market, by Application
    - 7.4.3.7.2Rest of LAMEA Arthritic Therapeutic Market, by Product Type

Chapter 8.Company Profiles

8.1AbbVie, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
8.2Pfizer, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Regional & Segmental Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Acquisition and Mergers:
- 8.2.6SWOT Analysis
8.3Amgen, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Acquisition and Mergers:
- 8.3.6SWOT Analysis
8.4Novartis AG
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expense
- 8.4.5Recent strategies and developments:
  - 8.4.5.1Trials and Approvals:
- 8.4.6SWOT Analysis
8.5F. Hoffmann-La Roche Ltd.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5SWOT Analysis
8.6Viatris, Inc.
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental Analysis
- 8.6.4Research & Development Expense
- 8.6.5Recent strategies and developments:
  - 8.6.5.1Trials and Approvals:
- 8.6.6SWOT Analysis
8.7Bausch Health Companies, Inc
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Sanofi S.A.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5Recent strategies and developments:
  - 8.8.5.1Partnerships, Collaborations, and Agreements:
- 8.8.6SWOT Analysis
8.9Merck & Co., Inc.
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5Recent strategies and developments:
  - 8.9.5.1Partnerships, Collaborations, and Agreements:
- 8.9.6SWOT Analysis
8.10.Bristol-Myers Squibb Company
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

関節炎治療の世界市場の規模、シェア、動向分析：用途別、製品タイプ別、地域別展望と予測（2023年～2030年）

Global Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Regional Outlook and Forecast, 2023 - 2030

目次

第1章市場範囲と調査手法

第2章市場要覧

第3章市場概要

第4章関節炎治療市場で展開されている最近の戦略

第5章世界の関節炎治療市場：用途別

第6章世界の関節炎治療市場：製品タイプ別

第7章世界の関節炎治療市場：地域別

第8章企業プロファイル

第9章関節炎治療市場の成功必須条件

LIST OF TABLES

Table of Contents

Chapter 1.Market Scope & Methodology

Chapter 2.Market at a Glance

Chapter 3.Market Overview

Chapter 4.Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5.Global Arthritic Therapeutic Market, by Application

Chapter 6.Global Arthritic Therapeutic Market, by Product Type

Chapter 7.Global Arthritic Therapeutic Market, by Region

Chapter 8.Company Profiles

Chapter 9.Winning Imperatives of Arthritic Therapeutic Market

関節炎治療の世界市場の規模、シェア、動向分析：用途別、製品タイプ別、地域別展望と予測（2023年～2030年）

Global Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Regional Outlook and Forecast, 2023 - 2030

目次

第1章 市場範囲と調査手法

第2章 市場要覧

第3章 市場概要

第4章 関節炎治療市場で展開されている最近の戦略

第5章 世界の関節炎治療市場：用途別

第6章 世界の関節炎治療市場：製品タイプ別

第7章 世界の関節炎治療市場：地域別

第8章 企業プロファイル

第9章 関節炎治療市場の成功必須条件

LIST OF TABLES

Table of Contents

Chapter 1.Market Scope & Methodology

Chapter 2.Market at a Glance

Chapter 3.Market Overview

Chapter 4.Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5.Global Arthritic Therapeutic Market, by Application

Chapter 6.Global Arthritic Therapeutic Market, by Product Type

Chapter 7.Global Arthritic Therapeutic Market, by Region

Chapter 8.Company Profiles

Chapter 9.Winning Imperatives of Arthritic Therapeutic Market

第1章市場範囲と調査手法

第2章市場要覧

第3章市場概要

第4章関節炎治療市場で展開されている最近の戦略

第5章世界の関節炎治療市場：用途別

第6章世界の関節炎治療市場：製品タイプ別

第7章世界の関節炎治療市場：地域別

第8章企業プロファイル

第9章関節炎治療市場の成功必須条件